Ignite Creation Date:
2024-05-06 @ 2:49 AM
Last Modification Date:
2024-10-26 @ 11:24 AM
Study NCT ID:
NCT02134080
Status:
TERMINATED
Last Update Posted:
2018-10-29
First Post:
2014-05-06
Brief Title:
FAAH Inhibitor Trial for Adults With Tourette Syndrome
Sponsor:
Yale University
Organization:
Yale University
Study Overview
Official Title:
FAAH Inhibitor Trial for Adults With Tourette Syndrome
Status:
TERMINATED
Status Verified Date:
2018-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
no more funding available
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this trial is to examine the safety tolerability and feasibility in the use of a FAAH inhibitor for the treatment of adults with Tourette syndrome
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None